MENU
+Compare
EPIX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$1.60
Change
-$0.00 (-0.00%)
Capitalization
71.02M

EPIX ESSA Pharma Forecast, Technical & Fundamental Analysis

a developer of small molecule drugs

Industry Biotechnology
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for EPIX with price predictions
Dec 20, 2024

Momentum Indicator for EPIX turns negative, indicating new downward trend

EPIX saw its Momentum Indicator move below the 0 level on December 04, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In of the 91 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EPIX entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for EPIX just turned positive on November 20, 2024. Looking at past instances where EPIX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EPIX advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.570) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). EPIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EPIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EPIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EPIX is expected to report earnings to rise 28.57% to -18 cents per share on February 06

ESSA Pharma EPIX Stock Earnings Reports
Q4'24
Est.
$-0.18
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.03
The last earnings report on December 17 showed earnings per share of -14 cents, beating the estimate of -20 cents. With 245.71K shares outstanding, the current market capitalization sits at 71.02M.
A.I. Advisor
published General Information

General Information

a developer of small molecule drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
999 West Broadway Street
Phone
+1 778 331-0962
Employees
50
Web
https://www.essapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CJET2.050.06
+2.85%
Chijet Motor Company
COLD21.480.45
+2.14%
Americold Realty Trust
SCHW74.310.69
+0.94%
Charles Schwab Corp (The)
SBLK14.800.08
+0.54%
Star Bulk Carriers Corp
FORR15.30-0.03
-0.20%
Forrester Research

EPIX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EPIX has been closely correlated with LOGC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if EPIX jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPIX
1D Price
Change %
EPIX100%
N/A
LOGC - EPIX
67%
Closely correlated
+1.51%
LXRX - EPIX
44%
Loosely correlated
-1.23%
ELAB - EPIX
33%
Loosely correlated
+8.94%
PCVX - EPIX
31%
Poorly correlated
+0.37%
MREO - EPIX
27%
Poorly correlated
+1.82%
More